4.7 Letter

Real-world experience of tocilizumab in systemic sclerosis: potential benefit on lung function for anti-topoisomerase-positive patients

Journal

RHEUMATOLOGY
Volume 60, Issue 8, Pages 3945-3946

Publisher

OXFORD UNIV PRESS
DOI: 10.1093/rheumatology/keab273

Keywords

-

Categories

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available